The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Treating viral hepatitis C: efficacy, side effects, and complications
Open accessAbstract
The treatment of hepatitis C has dramatically improved over the past decade. Unlike any other chronic viral infection, a significant proportion of patients with chronic hepatitis C can be cured. However, the current standard therapy--pegylated interferon alpha and ribavirin--has its limitations. Limited efficacy in patients with hepatitis C virus (HCV) genotype 1 and the side effect profile will necessitate the development of new therapeutic approaches. This review describes the efficacy and optimisation of the current standard therapy of hepatitis C and its problems in special patient populations. New treatment directions beyond interferon alpha based therapies are on the horizon.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989) · Science · doi:10.1126/science.2523562 · Cited by 6,875
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
Self-citationThe HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
McHutchison, J. G., Gordon, S. C., Schiff, E. R., Shiffman, M. L., Lee, W. M., Rustgi, V. K., Goodman, Z. D., Ling, M.-H., Cort, S., & Albrecht, J. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392101 · Cited by 3,465
Hadziyannis, S. J., Sette, H., Morgan, T. R., Balan, V., Diago, M., Marcellin, P., Ramadori, G., Bodenheimer, H., Bernstein, D., Rizzetto, M., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00010 · Cited by 2,836
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H.-G., Mizokami, M., et al. (2005) · Nature Medicine · doi:10.1038/nm1268 · Cited by 2,754
Poynard, T., Marcellin, P., Lee, S. S., Niederau, C., Minuk, G. S., Ideo, G., Bain, V., Heathcote, J., Zeuzem, S., Trepo, C., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)07124-4 · Cited by 2,318
Immunology of hepatitis B virus and hepatitis C virus infection
Rehermann, B., & Nascimbeni, M. (2005) · Nature Reviews Immunology · doi:10.1038/nri1573 · Cited by 1,627
Torriani, F. J., Rodriguez-Torres, M., Rockstroh, J. K., Lissen, E., Gonzalez-García, J., Lazzarin, A., Carosi, G., Sasadeusz, J., Katlama, C., Montaner, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040842 · Cited by 1,233
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C
Zeuzem, S., Feinman, S. V., Rasenack, J., Heathcote, E. J., Lai, M.-Y., Gane, E., O'Grady, J., Reichen, J., Diago, M., Lin, A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432301 · Cited by 1,220
Paroxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120
Course and outcome of hepatitis C
Hoofnagle, J. H. (2002) · Hepatology · doi:10.1002/hep.1840360704 · Cited by 1,084
Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha Interferon
Hoofnagle, J. H., Mullen, K. D., Jones, D. B., Rustgi, V., Di Bisceglie, A., Peters, M., Waggoner, J. G., Park, Y., & Jones, E. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612183152503 · Cited by 972
McHutchison, J. G., Manns, M., Patel, K., Poynard, T., Lindsay, K. L., Trepo, C., Dienstag, J., Lee, W. M., Mak, C., Garaud, J., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.35950 · Cited by 969
Self-citationChung, R. T., Andersen, J., Volberding, P., Robbins, G. K., Liu, T., Sherman, K. E., Peters, M. G., Koziel, M. J., Bhan, A. K., Alston, B., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032653 · Cited by 875
Peginterferon Alfa-2b and Ribavirin for 12 vs. 24 Weeks in HCV Genotype 2 or 3
Mangia, A., Santoro, R., Minerva, N., Ricci, G. L., Carretta, V., Persico, M., Vinelli, F., Scotto, G., Bacca, D., Annese, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042608 · Cited by 840
Davis, G. L., Wong, J. B., McHutchison, J. G., Manns, M. P., Harvey, J., & Albrecht, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50364 · Cited by 819
Self-citationTreatment of Acute Hepatitis C with Interferon Alfa-2b
Jaeckel, E., Cornberg, M., Wedemeyer, H., Santantonio, T., Mayer, J., Zankel, M., Pastore, G., Dietrich, M., Trautwein, C., & Manns, M. P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011232 · Cited by 800
Self-citationWedemeyer, H., He, X.-S., Nascimbeni, M., Davis, A. R., Greenberg, H. B., Hoofnagle, J. H., Liang, T. J., Alter, H., & Rehermann, B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3447 · Cited by 634
Self-citationProjecting future complications of chronic hepatitis C in the United States
Davis, G. L., Albright, J. E., Cook, S. F., & Rosenberg, D. M. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50073 · Cited by 576
Side effects of therapy of hepatitis C and their management
Fried, M. W. (2002) · Hepatology · doi:10.1002/hep.1840360730 · Cited by 556
Gerlach, J. T., Diepolder, H. M., Zachoval, R., Gruener, N. H., Jung, M.-C., Ulsenheimer, A., Schraut, W. W., Schirren, C. A., Waechtler, M., Backmund, M., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00668-1 · Cited by 524
ZEUZEM, S. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.02.007 · Cited by 448
Infection with GB Virus C and Reduced Mortality among HIV-Infected Patients
Tillmann, H. L., Heiken, H., Knapik-Botor, A., Heringlake, S., Ockenga, J., Wilber, J. C., Goergen, B., Detmer, J., McMorrow, M., Stoll, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010398 · Cited by 399
Self-citationLaguno, M., Murillas, J., Blanco, J. L., Martínez, E., Miquel, R., Sánchez-Tapias, J. M., Bargallo, X., García-Criado, A., Lazzari, E. D., Larrousse, M., et al. (2004) · AIDS · doi:10.1097/00002030-200409030-00003 · Cited by 387
Alberti, A., Clumeck, N., Collins, S., Gerlich, W., Lundgren, J., Palù, G., Reiss, P., Thiebaut, R., Weiland, O., Yazdanpanah, Y., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.003 · Cited by 382
Effect of Coinfection with GB Virus C on Survival among Patients with HIV Infection
Xiang, J., Wünschmann, S., Diekema, D. J., Klinzman, D., Patrick, K. D., George, S. L., & Stapleton, J. T. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003364 · Cited by 379
Mechanism of action of ribavirin in the combination treatment of chronic HCV infection
Lau, J. Y. N., Tam, R. C., Liang, J. T., & Hong, Z. (2002) · Hepatology · doi:10.1053/jhep.2002.32672 · Cited by 337
Persistent GB Virus C Infection and Survival in HIV-Infected Men
Williams, C. F., Klinzman, D., Yamashita, T. E., Xiang, J., Polgreen, P. M., Rinaldo, C., Liu, C., Phair, J., Margolick, J. B., Zdunek, D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030107 · Cited by 269
Wiegand, J., Buggisch, P., Boecher, W., Zeuzem, S., Gelbmann, C. M., Berg, T., Kauffmann, W., Kallinowski, B., Cornberg, M., Jaeckel, E., et al. (2006) · Hepatology · doi:10.1002/hep.21043 · Cited by 250
Self-citationZeuzem, S., Diago, M., Gane, E., Reddy, K. R., Pockros, P., Prati, D., Shiffman, M., Farci, P., Gitlin, N., O’Brien, C. B., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.050 · Cited by 246
Suicide associated with alfa-interferon therapy for chronic viral hepatitis
Janssen, H. L. A., Brouwer, J. T., van der Mast, R. C., & Schalm, S. W. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80402-7 · Cited by 229
Long–Term Outcome of Hepatitis C Virus Infection After Liver Transplantation
Böker, K. H., Dalley, G., Bahr, M. J., Maschek, H., Tillmann, H. L., Trautwein, C., Oldhaver, K., Bode, U., Pichlmayr, R., & Manns, M. P. (1997) · Hepatology · doi:10.1002/hep.510250137 · Cited by 216
Self-citationDevelopment of thyroid disease during therapy of chronic viral hepatitis with interferon alfa
Lisker-Melman, M., Di Bisceglie, A. M., Usala, S. J., Weintraub, B., Murray, L. M., & Hoofnagle, J. H. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90348-3 · Cited by 212
Marazuela, M., García‐Buey, L., González‐Fernández, B., García‐Monzón, C., Arranz, A., Borque, M. J., & Moreno‐Otero, R. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.751768.x · Cited by 211
Hofer, H., Watkins-Riedel, T., Janata, O., Penner, E., Holzmann, H., Steindl-Munda, P., Gangl, A., & Ferenci, P. (2003) · Hepatology · doi:10.1053/jhep.2003.50019 · Cited by 203
Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience
Koenig, S. P., Léandre, F., & Farmer, P. E. (2004) · AIDS · doi:10.1097/00002030-200406003-00005 · Cited by 198
BLATT, L. M., DAVIS, J. M., KLEIN, S. B., & TAYLOR, M. W. (1996) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1996.16.489 · Cited by 192
Tong, M. J., Reddy, K. R., Lee, W. M., Pockros, P. J., Hoefs, J. C., Keeffe, E. B., Hollinger, F. B., Hathcote, E. J., White, H., Foust, R. T., et al. (1997) · Hepatology · doi:10.1002/hep.510260330 · Cited by 179
Schaefer, M., Schwaiger, M., Garkisch, A. S., Pich, M., Hinzpeter, A., Uebelhack, R., Heinz, A., van Boemmel, F., & Berg, T. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.01.020 · Cited by 175
Kamal, S. M., Ismail, A., Graham, C. S., He, Q., Rasenack, J. W., Peters, T., Tawil, A. A., Fehr, J. J., Khalifa, K. E. S., Madwar, M. M., et al. (2004) · Hepatology · doi:10.1002/hep.20266 · Cited by 163
Santantonio, T. A., Fasano, M., Sinisi, E., Guastadisegni, A., Casalino, C., Mazzola, M., Francavilla, R., & Pastore, G. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.021 · Cited by 151
Treatment of Chronic Hepatitis C with Amantadine
Smith, J. P. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018857314351 · Cited by 139
Autoimmunity and extrahepatic manifestations in hepatitis C virus infection
Manns, M. P., & Rambusch, E. G. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80372-9 · Cited by 134
Self-citationNevens, F., Roskams, T., Vlierberghe, H. V., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50474 · Cited by 132
Dalekos, G. N., Wedemeyer, H. H., Obermayer–Straub, P., Kayser, A., Barut, A., Frank, H., & Manns, M. P. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80092-0 · Cited by 98
Self-citationTreatment of chronic hepatitis C with PEGylated interferon and ribavirin
Cornberg, M., Wedemeyer, H. H., & Manns, M. P. (2002) · Current Gastroenterology Reports · doi:10.1007/s11894-002-0034-y · Cited by 89
Self-citationTodros, L., Saracco, G. M., Durazzo, M., Abate, M. L., Touscoz, G. A., Scaglione, L., Verme, G., & Rizzetto, M. (1995) · Hepatology · doi:10.1002/hep.1840220506 · Cited by 80
Bräu, N., Rodriguez‐Torres, M., Prokupek, D., Bonacini, M., Giffen, C. A., Smith, J. J., Frost, K. R., & Kostman, J. R. (2004) · Hepatology · doi:10.1002/hep.20107 · Cited by 71
Wesche, B., Jaeckel, E., Trautwein, C., Wedemeyer, H., Falorni, A., Frank, H., Mühlen, A. V. Z., Manns, M.-P., & Brabant, G. E. (2001) · Gut · doi:10.1136/gut.48.3.378 · Cited by 69
Self-citationBerg, T., Kronenberger, B., Hinrichsen, H. M., Gerlach, T. J., Buggisch, P., Herrmann, E. M., Spengler, U., Goeser, T., Nasser, S., Wursthorn, K., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50219 · Cited by 65
Pratiwi, R., Fletcher, L. M., Pyper, W. R., Do, K.-A., Crawford, D. H., Powell, L. W., & Jazwinska, E. C. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80161-5 · Cited by 50
Chung, H., Kudo, M., Kumada, T., Katsushima, S., Okano, A., Nakamura, T., Osaki, Y., KOHIGASHI, K., Yamashita, Y., Komori, H., et al. (2003) · Journal of Gastroenterology · doi:10.1007/s00535-003-1156-1 · Cited by 38
Teuber, G., Berg, T., Naumann, U., Raedle, J., Brinkmann, S., Hopf, U., & Zeuzem, S. (2001) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2001.00297.x · Cited by 34
Sulkowski, M., Felizarta, F., Smith, C. C., Slim, J., Berggren, R., Goodman, R., Ball, L., Khalili, M., & Dieterich, D. T. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200404150-00004 · Cited by 21
Treatment of Hepatitis C in HIV-Infected Patients: Significant Progress But Not the Final Step
Manns, M. P., & Wedemeyer, H. H. (2004) · JAMA · doi:10.1001/jama.292.23.2909 · Cited by 16
Self-citation
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
(2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.023 · Cited by 1,088
Domingo, E., Sheldon, J., & Perales, C. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05023-11 · Cited by 1,009
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
(2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.003 · Cited by 855
Metadata
- Authors
- Manns, M. P., Wedemeyer, H., & Cornberg, M.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2006-08-11
- Volume
- 55
- Issue
- 9
- Pages
- 1350-1359
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2107713887
- Cited by
- 659
- References
- 59
- FWCI
- 26.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.